1st 'Biosimilar' OK'd to Prevent Chemo-Related Infections

TUESDAY, June 5, 2018 — The first “biosimilar” drug to Neulasta, designed to ward off infections related to chemotherapy, has been approved by the U.S. Food and Drug Administration.
Fulphila (pegfilgrastim) is approved for people with symptoms of…
Source: Topamax